SCHEMBL13282079

SCHEMBL13282079

CC(C)c1noc(C2CC3CCC(C2)N3C(=O)OC(C)(C)C)n1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CHRM2 P08172 1/20 0.49
▸ CHRM1 P11229 1/20 0.49
▸ CHRM3 P20309 1/20 0.49
▸ EPHX2 P34913 1/20 0.40
▸ PREP P48147 3/20 0.38
▸ HCRTR1 O43613 1/20 0.37
▸ HCRTR2 O43614 1/20 0.37
▸ CCR5 P51681 1/20 0.37
▸ KCNH2 Q12809 1/20 0.37
▸ CHRM4 P08173 1/20 0.36
▸ EIF2AK4 Q9P2K8 1/20 0.36
▸ HSD11B1 P28845 1/20 0.35
▸ GPR119 Q8TDV5 3/20 0.35
▸ KCNK3 O14649 1/20 0.35
▸ KCNK9 Q9NPC2 1/20 0.35
▸ CNR2 P34972 1/20 0.35
▸ KAT2B Q92831 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12069832 0.81 EPHX2 (0.51) EPHX2CCR5KCNH2CHRM4GPR119
SCHEMBL15931983 0.76 ALDH1A1 (0.44) EPHX2HCRTR1HCRTR2CCR5KCNH2
SCHEMBL19472916 0.75 ALDH1A1 (0.51) PREP
SCHEMBL10518999 0.75 EPHX2 (0.36) CHRM2CHRM1CHRM3EPHX2HCRTR1
SCHEMBL15932009 0.74 PTPN1 (0.37) CHRM2CHRM1CHRM3EPHX2HCRTR1
SCHEMBL1128582 0.71 EPHX2 (0.42) EPHX2HCRTR1HCRTR2CCR5KCNH2
SCHEMBL1128579 0.71 EPHX2 (0.42) EPHX2HCRTR1HCRTR2CCR5KCNH2
SCHEMBL4355370 0.71 EPHX2 (0.42) EPHX2HCRTR1HCRTR2CCR5KCNH2
SCHEMBL1128755 0.70 ALDH1A1 (0.51) EPHX2HCRTR1HCRTR2CCR5KCNH2
SCHEMBL5004068 0.70 CCR5 (0.45) EPHX2HCRTR1HCRTR2CCR5KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010075273-A1 BICYCLIC HETEROCYCLE DERIVATIVES AND METHODS OF USE THEREOF SCHERING CORPORATION (US) 2010-07-01 — — WO disclosed
Send feedback